Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New combo test could spot liver damage before it's too late

NCT ID NCT04666402

First seen Feb 18, 2026 · Last updated Jun 16, 2026 · Updated 17 times

Summary

This study looks at 1,200 adults referred for liver checks to see if combining blood markers, genetic data, and gut bacteria analysis can detect liver scarring earlier than current methods. The goal is to identify advanced liver disease in the community and reduce unnecessary specialist visits. Participants provide samples and data, but no treatment is given.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Manchester University NHS Foundation Trust

    RECRUITING

    Manchester, Greater Manchester, M13 9WL, United Kingdom

    Contact Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

alcoholic liver disease cirrhosis of liver fibrotic liver disease metabolic dysfunction-associated steatohepatitis metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.